<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>51</viewCount><searchCount>0</searchCount></scores><additional><submitter>George M</submitter><funding>NCATS NIH HHS</funding><funding>NINR NIH HHS</funding><funding>NIH HHS</funding><pagination>876-887</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8260028</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>75(4)</volume><pubmed_abstract>&lt;h4>Aim&lt;/h4>To evaluate the preliminary effectiveness of the BRief Evaluation of Asthma THerapy intervention, a 7-min primary care provider-delivered shared decision-making protocol that uses motivational interviewing to address erroneous asthma disease and medication beliefs.&lt;h4>Design&lt;/h4>A multi-centre masked two-arm group-randomized clinical trial.&lt;h4>Methods&lt;/h4>This 2-year pilot study is funded (September 2016) by the National Institute of Nursing Research. Eight providers will be randomized to one of two arms: the active intervention (N = 4) or a dose-matched attention control (N = 4). Providers will deliver the intervention to which they were randomized to 10 Black adult patients with uncontrolled asthma (N = 80). Patients will be followed three months postintervention to test the preliminary intervention effects on asthma control (primary outcome) and on medication adherence, lung function, and asthma-related quality of life (secondary outcomes).&lt;h4>Discussion&lt;/h4>This study will evaluate the preliminary impact of a novel shared decision-making intervention delivered in a real world setting to address erroneous disease and medication beliefs as a means of improving asthma control in Black adults. Results will inform a future, large-scale randomized trial with sufficient power to test the intervention's effectiveness.&lt;h4>Impact&lt;/h4>Shared decision-making is an evidence-based intervention with proven effectiveness when implemented in the context of labour- and time-intensive research protocols. Medication adherence is linked with the marked disparities evident in poor and minority adults with asthma. Addressing this requires a novel multifactorial approach as we have proposed. To ensure sustainability, shared decision-making interventions must be adapted to and integrated into real-world settings.&lt;h4>Trial registration&lt;/h4>Registered at clincialtrials.gov as NCT03036267 and NCT03300752.</pubmed_abstract><journal>Journal of advanced nursing</journal><pubmed_title>Shared decision-making in the BREATHE asthma intervention trial: A research protocol.</pubmed_title><pmcid>PMC8260028</pmcid><funding_grant_id>R21 NR016507</funding_grant_id><funding_grant_id>TL1 TR001875</funding_grant_id><pubmed_authors>Glanz K</pubmed_authors><pubmed_authors>Poghosyan L</pubmed_authors><pubmed_authors>Bruzzese JM</pubmed_authors><pubmed_authors>George M</pubmed_authors><pubmed_authors>Chung A</pubmed_authors><pubmed_authors>Norful AA</pubmed_authors><pubmed_authors>Jia H</pubmed_authors><pubmed_authors>Pantalon MV</pubmed_authors><pubmed_authors>Coleman D</pubmed_authors><pubmed_authors>Sommers MLS</pubmed_authors><view_count>51</view_count></additional><is_claimable>false</is_claimable><name>Shared decision-making in the BREATHE asthma intervention trial: A research protocol.</name><description>&lt;h4>Aim&lt;/h4>To evaluate the preliminary effectiveness of the BRief Evaluation of Asthma THerapy intervention, a 7-min primary care provider-delivered shared decision-making protocol that uses motivational interviewing to address erroneous asthma disease and medication beliefs.&lt;h4>Design&lt;/h4>A multi-centre masked two-arm group-randomized clinical trial.&lt;h4>Methods&lt;/h4>This 2-year pilot study is funded (September 2016) by the National Institute of Nursing Research. Eight providers will be randomized to one of two arms: the active intervention (N = 4) or a dose-matched attention control (N = 4). Providers will deliver the intervention to which they were randomized to 10 Black adult patients with uncontrolled asthma (N = 80). Patients will be followed three months postintervention to test the preliminary intervention effects on asthma control (primary outcome) and on medication adherence, lung function, and asthma-related quality of life (secondary outcomes).&lt;h4>Discussion&lt;/h4>This study will evaluate the preliminary impact of a novel shared decision-making intervention delivered in a real world setting to address erroneous disease and medication beliefs as a means of improving asthma control in Black adults. Results will inform a future, large-scale randomized trial with sufficient power to test the intervention's effectiveness.&lt;h4>Impact&lt;/h4>Shared decision-making is an evidence-based intervention with proven effectiveness when implemented in the context of labour- and time-intensive research protocols. Medication adherence is linked with the marked disparities evident in poor and minority adults with asthma. Addressing this requires a novel multifactorial approach as we have proposed. To ensure sustainability, shared decision-making interventions must be adapted to and integrated into real-world settings.&lt;h4>Trial registration&lt;/h4>Registered at clincialtrials.gov as NCT03036267 and NCT03300752.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Apr</publication><modification>2022-02-10T18:31:45.154Z</modification><creation>2022-02-10T18:31:45.154Z</creation></dates><accession>S-EPMC8260028</accession><cross_references><pubmed>30479020</pubmed><doi>10.1111/jan.13916</doi></cross_references></HashMap>